139 related articles for article (PubMed ID: 36669966)
1. COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
Bedston S; Lowthian E; Jarvis CI; Akbari A; Beggs J; Bradley D; de Lusignan S; Griffiths R; Herbert L; Hobbs R; Kerr S; Lyons J; Midgley W; Owen RK; Quint JK; Tsang R; Torabi F; Sheikh A; Lyons RA
Vaccine; 2023 Feb; 41(7):1378-1389. PubMed ID: 36669966
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination in pregnancy: the impact of multimorbidity and smoking status on vaccine hesitancy, a cohort study of 25,111 women in Wales, UK.
Mhereeg M; Jones H; Kennedy J; Seaborne M; Parker M; Kennedy N; Akbari A; Zuccolo L; Azcoaga-Lorenzo A; Davies A; Nirantharakumar K; Brophy S
BMC Infect Dis; 2023 Sep; 23(1):594. PubMed ID: 37697235
[TBL] [Abstract][Full Text] [Related]
3. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales.
Bedston S; Akbari A; Jarvis CI; Lowthian E; Torabi F; North L; Lyons J; Perry M; Griffiths LJ; Owen RK; Beggs J; Chuter A; Bradley DT; de Lusignan S; Fry R; Richard Hobbs FD; Hollinghurst J; Katikireddi SV; Murphy S; O'Reily D; Robertson C; Shi T; Tsang RSM; Sheikh A; Lyons RA
Vaccine; 2022 Feb; 40(8):1180-1189. PubMed ID: 35042645
[TBL] [Abstract][Full Text] [Related]
5. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study.
Turpin A; Semenzato L; Le Vu S; Jabagi MJ; Bouillon K; Drouin J; Bertrand M; Kanagaratnam L; Weill A; Dray-Spira R; Zureik M; Botton J
J Infect Public Health; 2024 Jul; 17(7):102450. PubMed ID: 38823086
[TBL] [Abstract][Full Text] [Related]
8. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
Basso P; Negro C; Cegolon L; Larese Filon F
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
[No Abstract] [Full Text] [Related]
9. Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan.
Igari H; Asano H; Murata S; Yoshida T; Kawasaki K; Kageyama T; Ikeda K; Koshikawa H; Okuda Y; Urushihara M; Chiba H; Yahaba M; Taniguchi T; Matsushita K; Yoshino I; Yokote K; Nakajima H
J Infect Chemother; 2022 Nov; 28(11):1483-1488. PubMed ID: 35870791
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.
Nguyen VG; Yavlinsky A; Beale S; Hoskins S; Byrne TE; Lampos V; Braithwaite I; Fong WLE; Fragaszy E; Geismar C; Kovar J; Navaratnam AMD; Patel P; Shrotri M; Weber S; Hayward AC; Aldridge RW
Int J Epidemiol; 2023 Apr; 52(2):342-354. PubMed ID: 36655537
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
12. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
13. Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.
Cohen MJ; Oster Y; Moses AE; Spitzer A; Benenson S;
JAMA Netw Open; 2022 Aug; 5(8):e2224657. PubMed ID: 35917125
[TBL] [Abstract][Full Text] [Related]
14. The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers.
Jamalidoust M; Eilami O; Ashkan Z; Ziyaeyan M; Aliabadi N; Habibi M
Virol J; 2023 Aug; 20(1):182. PubMed ID: 37596593
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022.
Cegolon L; Negro C; Pesce M; Filon FL
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851360
[No Abstract] [Full Text] [Related]
16. Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals.
Momplaisir FM; Kuter BJ; Ghadimi F; Browne S; Nkwihoreze H; Feemster KA; Frank I; Faig W; Shen AK; Offit PA; Green-McKenzie J
JAMA Netw Open; 2021 Aug; 4(8):e2121931. PubMed ID: 34459907
[TBL] [Abstract][Full Text] [Related]
17. The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis.
Oster Y; Benenson S; Nir-Paz R; Buda I; Cohen MJ
Clin Microbiol Infect; 2022 May; 28(5):735.e1-735.e3. PubMed ID: 35143997
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
19. Severity and Outcome of Post-Vaccine COVID-19 among Healthcare Workers in a University Hospital in India.
Vishnoi J; Sharma RK; Patel J; Sharma JC; Sharma KR; Mehta U
J Med Life; 2023 May; 16(5):782-793. PubMed ID: 37520491
[TBL] [Abstract][Full Text] [Related]
20. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
